Medical Condition News

RSS
Vermillion receives USPTO patent for PAD biomarker

Vermillion receives USPTO patent for PAD biomarker

SCRI to lead clinical development of AstraZeneca's novel targeted oncology compound

SCRI to lead clinical development of AstraZeneca's novel targeted oncology compound

Common rubber products can cause contact allergy: Study

Common rubber products can cause contact allergy: Study

BPH, hair loss prevention drugs may produce adverse side effects in men

BPH, hair loss prevention drugs may produce adverse side effects in men

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Patients who consume painkillers may face cardiovascular risk

Patients who consume painkillers may face cardiovascular risk

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

Bone marrow stem cell transplantation provides therapeutic benefit to patients with end-stage liver disease

FemmePharma completes FP 1097 Phase II clinical trial in women with OAB

FemmePharma completes FP 1097 Phase II clinical trial in women with OAB

Eric Lancaster receives NORD grant to study stiff-person syndrome

Eric Lancaster receives NORD grant to study stiff-person syndrome

Pain services severely inadequate: report

Pain services severely inadequate: report

Stigma remains over Major Depressive Disorder

Stigma remains over Major Depressive Disorder

Nicotine may act as treatment for some symptoms of schizophrenia

Nicotine may act as treatment for some symptoms of schizophrenia

Race, ethnicity and geography influence colon cancer screening

Race, ethnicity and geography influence colon cancer screening

TearLab's Osmolarity test made available at point-of-care

TearLab's Osmolarity test made available at point-of-care

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

Cyclacel opens enrollment of sapacitabine Phase 3 trial for AML

Cyclacel opens enrollment of sapacitabine Phase 3 trial for AML

DynaVox Mayer-Johnson announces Boardmaker Player for Windows

DynaVox Mayer-Johnson announces Boardmaker Player for Windows

Lilly and Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Lilly and Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.